Roche Gets Illumina Unit's DNA Testing Patent Revoked
Roche has persuaded a European appeals panel to revoke an Illumina Inc. subsidiary's patent over a way of detecting fetal DNA in maternal blood, proving that the technique isn't inventive....To view the full article, register now.
Already a subscriber? Click here to view full article